Payment overview · 2025
General Payments
$15.66
1 reported records · 1 companies
Healthcare provider profile · identity verified
Laura Ellen Lasack, MD
Allopathic & Osteopathic Physicians|Family Medicine · MARSHALLTOWN, IA · NPI 1861468084
Verified facts
What the public records show
CMS Open Payments records show Laura Ellen Lasack, MD received $15.66 in general payments during 2025 across 1 reported records.
Dexcom, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $15.66 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $15.66 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $15.66 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 854 | 205 |
| Atorvastatin Calcium | Atorvastatin Calcium | 652 | 169 |
| Omeprazole | Omeprazole | 467 | 137 |
| Losartan Potassium | Losartan Potassium | 432 | 119 |
| Simvastatin | Simvastatin | 406 | 107 |
| Amlodipine Besylate | Amlodipine Besylate | 387 | 98 |
| Lisinopril | Lisinopril | 334 | 84 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 321 | 95 |
| Metoprolol Succinate | Metoprolol Succinate | 310 | 82 |
| Escitalopram Oxalate | Escitalopram Oxalate | 285 | 77 |
| Gabapentin | Gabapentin | 277 | 64 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 217 | 54 |
| Pantoprazole Sodium | Pantoprazole Sodium | 209 | 57 |
| Tramadol Hcl | Tramadol Hcl | 197 | 55 |
| Trazodone Hcl | Trazodone Hcl | 192 | 57 |
| Alendronate Sodium | Alendronate Sodium | 181 | 53 |
| Metformin Hcl | Metformin Hcl | 169 | 49 |
| Famotidine | Famotidine | 166 | 53 |
| Bupropion Xl | Bupropion Hcl | 164 | 52 |
| Hydrochlorothiazide | Hydrochlorothiazide | 162 | 50 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 161 | 41 |
| Furosemide | Furosemide | 157 | 52 |
| Metformin Hcl Er | Metformin Hcl | 153 | 39 |
| Sertraline Hcl | Sertraline Hcl | 146 | 43 |
| Potassium Chloride | Potassium Chloride | 143 | 44 |
| Eliquis | Apixaban | 136 | 28 |
| Prednisone | Prednisone | 135 | 83 |
| Allopurinol | Allopurinol | 129 | 36 |
| Pravastatin Sodium | Pravastatin Sodium | 124 | 32 |
| Metoprolol Tartrate | Metoprolol Tartrate | 123 | 34 |
| Diclofenac Sodium | Diclofenac Sodium | 115 | 28 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 114 | 16 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 109 | 53 |
| Ozempic | Semaglutide | 109 | 24 |
| Tamsulosin Hcl | Tamsulosin Hcl | 105 | 33 |
| Alprazolam | Alprazolam | 101 | 20 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 97 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 92 | 30 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 91 | 25 |
| Spironolactone | Spironolactone | 91 | 21 |
| Fluoxetine Hcl | Fluoxetine Hcl | 86 | 25 |
| Tizanidine Hcl | Tizanidine Hcl | 78 | 40 |
| Atenolol | Atenolol | 77 | 19 |
| Duloxetine Hcl | Duloxetine Hcl | 77 | 25 |
| Januvia | Sitagliptin Phosphate | 77 | 12 |
| Lorazepam | Lorazepam | 76 | 38 |
| Carvedilol | Carvedilol | 75 | 17 |
| Oxycodone Hcl | Oxycodone Hcl | 75 | 15 |
| Clopidogrel | Clopidogrel Bisulfate | 73 | 23 |
| Pregabalin | Pregabalin | 73 | 15 |
| Warfarin Sodium | Warfarin Sodium | 72 | 21 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 71 | 19 |
| Donepezil Hcl | Donepezil Hcl | 70 | 19 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 68 | 20 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 64 | 41 |
| Ipratropium Bromide | Ipratropium Bromide | 61 | 28 |
| Synthroid | Levothyroxine Sodium | 61 | 11 |
| Jardiance | Empagliflozin | 60 | 12 |
| Glimepiride | Glimepiride | 58 | 16 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 56 | 20 |
| Montelukast Sodium | Montelukast Sodium | 55 | 16 |
| Zolpidem Tartrate | Zolpidem Tartrate | 54 | 16 |
| Lovastatin | Lovastatin | 53 | 13 |
| Meloxicam | Meloxicam | 52 | 20 |
| Buspirone Hcl | Buspirone Hcl | 51 | 12 |
| Farxiga | Dapagliflozin Propanediol | 50 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 47 | 14 |
| Breo Ellipta | Fluticasone/Vilanterol | 47 | suppressed |
| Fentanyl | Fentanyl | 47 | suppressed |
| Memantine Hcl | Memantine Hcl | 46 | 12 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 45 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 45 | 11 |
| Xarelto | Rivaroxaban | 45 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 42 | 12 |
| Cephalexin | Cephalexin | 41 | 31 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 40 | 13 |
| Trulicity | Dulaglutide | 39 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 38 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 38 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 36 | 28 |
| Mirtazapine | Mirtazapine | 35 | suppressed |
| Topiramate | Topiramate | 35 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 34 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 33 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 32 | suppressed |
| Estradiol | Estradiol | 31 | 15 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 30 | 28 |
| Baclofen | Baclofen | 30 | suppressed |
| Aripiprazole | Aripiprazole | 29 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 28 | 25 |
| Mounjaro | Tirzepatide | 28 | suppressed |
| Clonazepam | Clonazepam | 27 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Ezetimibe | Ezetimibe | 26 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 26 | suppressed |
| Nystatin | Nystatin | 26 | 17 |
| Jantoven | Warfarin Sodium | 25 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 25 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 24 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 24 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 23 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 23 | suppressed |
| Ketoconazole | Ketoconazole | 23 | suppressed |
| Nabumetone | Nabumetone | 23 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 23 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 23 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 23 | 12 |
| Tradjenta | Linagliptin | 22 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 21 | 17 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 20 | suppressed |
| Lactulose | Lactulose | 20 | suppressed |
| Temazepam | Temazepam | 20 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 19 | suppressed |
| Nitroglycerin | Nitroglycerin | 19 | 16 |
| Symbicort | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Verapamil Er | Verapamil Hcl | 19 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 18 | 17 |
| Ondansetron Odt | Ondansetron | 18 | 11 |
| Rybelsus | Semaglutide | 18 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 17 | suppressed |
| Lamotrigine | Lamotrigine | 17 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 17 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 17 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 16 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Methocarbamol | Methocarbamol | 16 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 16 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 16 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 15 | suppressed |
| Levoxyl | Levothyroxine Sodium | 15 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 15 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 15 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 14 | suppressed |
| Digoxin | Digoxin | 14 | suppressed |
| Finasteride | Finasteride | 14 | suppressed |
| Nyamyc | Nystatin | 14 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 14 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 14 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 13 | suppressed |
| Cilostazol | Cilostazol | 13 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Klor-Con 10 | Potassium Chloride | 13 | suppressed |
| Latanoprost | Latanoprost | 13 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 13 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 12 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 11 | suppressed |
| Glipizide Er | Glipizide | 11 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Nucynta | Tapentadol Hcl | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
| Valsartan | Valsartan | 11 | suppressed |
| Veozah | Fezolinetant | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $15.66 · 1 records | Dexcom, Inc. | Dexcom G6 Transmitter | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error